Fluorexetamine, also known as 3-F-2′-Oxo-PCE or 2′-Oxo-PCE, is a research chemical belonging to the class of dissociative anesthetics. It has a similar chemical structure to other popular dissociatives such as ketamine and PCP, but with unique properties that make it an attractive research tool for scientists and pharmacologists.
The molecular weight of Fluorexetamine is 255.33 g/mol, and its chemical formula is C15H16FNO. Its CAS (Chemical Abstracts Service) number is 1445752-09-9. It is a white crystalline powder that is soluble in organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO).
Fluorexetamine has been found to have a high affinity for the N-methyl-D-aspartate (NMDA) receptor, which is a receptor involved in the regulation of synaptic plasticity and memory function in the brain. It also acts on the dopamine transporter, increasing the release of dopamine in the brain and leading to euphoria and a sense of well-being.
Researchers have studied Fluorexetamine for its potential use in treating depression, anxiety, and post-traumatic stress disorder (PTSD). Its unique properties make it a promising candidate for further research in these areas.
As with any research chemical, it is important to handle Fluorexetamine with care and take appropriate safety precautions when working with it. It should only be used in a laboratory setting by trained professionals who are experienced in handling and analyzing chemicals.
In summary, Fluorexetamine is a dissociative anesthetic with a unique chemical structure and high affinity for the NMDA receptor. It has potential therapeutic applications for treating depression, anxiety, and PTSD, and is a promising research tool for studying the mechanisms of brain function and pharmacology.